UPClytics
View All Parties

Samsung Bioepis NL B.V.

Operating company
Total cases
9 (4 active)
Claimant-side
6
Respondent-side
3

Samsung Bioepis NL B.V. has been party to nine Unified Patent Court cases, 6 times as claimant and 3 times as respondent. The most recent on record is UPC CoA 750/2025 at the Court of Appeal, against Alexion Pharmaceuticals, Inc.

Adversary analytics require an account

Sign in to see top opponents and the firms representing each side.

Sign in or create an account
Recent cases
View all cases
  • 2025-08-14UPC CoA 750/2025Samsung Bioepis NL B.V. v Alexion Pharmaceuticals, Inc.
  • 2025-08-13UPC CoA 744/2025WithdrawnSamsung Bioepis NL B.V. v Alexion Pharmaceuticals, Inc.
  • 2025-07-22UPC CFI 674/2025Samsung Bioepis NL B.V. v Alexion Pharmaceuticals, Inc.
  • 2025-01-23UPC CFI 51/2025Samsung Bioepis NL B.V. v Alexion Pharmaceuticals, Inc.
  • 2025-01-22UPC CFI 40/2025Costs onlySamsung Bioepis NL B.V. v Alexion Pharmaceuticals, Inc.
  • 2024-11-08UPC APP 60271/2024Name not displayed for GDPR reasons. Represented by Jochen HÖHFELD v Alexion Pharmaceuticals, Inc.
  • 2024-07-26UPC APP 43786/2024Costs onlySamsung Bioepis NL B.V. v Alexion Pharmaceuticals, Inc.
  • 2024-07-11UPC CoA 402/2024PI deniedAlexion Pharmaceuticals, Inc. v Samsung Bioepis NL B.V.
  • 2024-03-19UPC CFI 123/2024PI deniedAlexion Pharmaceuticals, Inc. v Samsung Bioepis NL B.V.